E0 ConsensusModerate confidencePEM not requiredSystematic-ReviewPeer-reviewedReviewed
Effects of human papillomavirus (HPV) vaccination programmes on community rates of HPV-related disease and harms from vaccination.
Henschke, Nicholas, Bergman, Hanna, Buckley, Brian S et al. · The Cochrane database of systematic reviews · 2025 · DOI
Quick Summary
This large review looked at whether HPV vaccines (which prevent certain cancers) are safe and effective by studying millions of people across many countries. The researchers found that HPV vaccination significantly reduces cervical cancer and related precancerous conditions, especially when given to young teens, and that the vaccine is not associated with chronic fatigue syndrome, ME, or other serious conditions that some people worry about.
Why It Matters
This systematic review is directly relevant to ME/CFS research because it provides the highest-quality evidence available that HPV vaccination does not increase the risk of chronic fatigue syndrome or myalgic encephalomyelitis—conditions that have been subject to substantial public concern and misinformation. For patients with ME/CFS considering vaccination or investigating potential triggers, this evidence offers reassurance based on analysis of multiple large population studies rather than anecdotal reports.
Observed Findings
- In females vaccinated at or before age 16, HPV vaccination reduced cervical cancer risk by 80% (RR 0.20, 95% CI 0.09–0.44) based on 4.54 million person-years in five cohort studies.
- CIN3+ (cervical intraepithelial neoplasia grade 3 or higher) incidence decreased by 74% in vaccinated females (RR 0.26, 95% CI 0.12–0.56) in long-term follow-up of 1.5 million females.
- Anogenital warts incidence was reduced by 53% in the long term (RR 0.47, 95% CI 0.36–0.61) across 13 studies covering 4.5 million person-years.
- Across multiple study designs with moderate-certainty evidence, HPV vaccination was not associated with increased risk of chronic fatigue syndrome/ME, POTS, paralysis, CRPS, premature ovarian failure, or infertility.
Inferred Conclusions
- HPV vaccination provides substantial long-term protection against cervical cancer and precancerous lesions when administered in early adolescence, with greater benefit in younger vaccinees.
- Population-level data from diverse countries and study designs consistently demonstrate that HPV vaccination does not increase the risk of the serious adverse events most commonly reported on social media, including chronic fatigue syndrome and ME.
- The benefit-risk profile of HPV vaccination is highly favorable at the population level, particularly in resource-limited settings where cervical cancer screening is less accessible.
Remaining Questions
- Why do some individual people report symptom onset following HPV vaccination despite no detectable population-level signal, and what mechanisms might explain rare idiosyncratic reactions?
What This Study Does Not Prove
This review does not prove that HPV vaccination cannot trigger ME/CFS in rare individual cases, as population-level studies cannot detect extremely rare adverse events and the authors note that no studies specifically examined community rates of serious adverse events. The absence of an association in large populations does not eliminate the possibility of idiosyncratic reactions in susceptible individuals, though it indicates such reactions, if they occur, are not attributable to the vaccine at a detectable population level. Additionally, this study is about HPV vaccination specifically and does not speak to other vaccines or medications.
Tags
Symptom:Fatigue
Method Flag:Mixed Cohort
Metadata
- DOI
- 10.1002/14651858.CD015363.pub2
- PMID
- 41276264
- Review status
- Editor reviewed
- Evidence level
- Higher-level evidence type — systematic reviews, meta-analyses, guidelines, or major syntheses (study type, not a quality guarantee)
- Last updated
- 12 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.